Health
Oncologists use immunotherapy at faster rates for trial-ineligible patients, study finds – News-Medical.Net
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients…
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the Perelman School of Medicine…
Continue Reading
-
Noosa News10 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News11 hours agoMotorcyclist dies in crash with truck
-
Noosa News12 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General17 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging